Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

A new one-step test can quickly identify skin cancer during surgery.

Topical glucocorticoids thin the skin and change collagen structure.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Upadacitinib improved multiple immune-related conditions in one patient.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Tattoos may trigger autoimmune symptoms in some people.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

Targeting specific cell interactions may help treat skin fibrosis.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Cells can change to help heal wounds better.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

The role of γδT-cells in causing alopecia areata remains unclear.

Mint water extract boosts protective enzymes in skin cells.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Human hair follicles have a unique way of using energy and might use the Cori cycle; blocking CCR5 could help treat hair loss.